bluebird bio, Inc.
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of tran…
Biotechnology
US, Cambridge [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
bluebird bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDbluebird bio, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of bluebird bio, Inc..
If you want to see a demo, head over to the financial segments of AAPL